FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Ajanta Pharma Buyback 2024 and eClerx Services Buyback 2024.
Ajanta Pharma Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while eClerx Services Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Ajanta Pharma Limited | eClerx Services Limited | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ||||||||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
Listing At | BSE, NSE | BSE, NSE | ||||||||||||||||||
Face Value | ₹2 per share | ₹10 per share | ||||||||||||||||||
Buyback Price | ₹2770 per share | ₹2800 per share | ||||||||||||||||||
Issue Size | 10,28,881 shares | 13,75,000 shares | ||||||||||||||||||
Issue Size (Amount) | ₹285.00 Crores | ₹385.00 Crores | ||||||||||||||||||
Buyback Ratio |
|
|
||||||||||||||||||
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited | ||||||||||||||||||
Lead Managers | Vivro Financial Services Private Limited | Emkay Global Financial Services Ltd | ||||||||||||||||||
Necessity of the buyback | Buyback is being undertaken, inter-alia, for the following reasons:
|
The Buy-Back is being undertaken, inter-alia, for the following reasons:
|
Ajanta Pharma Buyback 2024 and eClerx Services Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback 2024 Buyback record date is May 30, 2024. eClerx Services Buyback 2024 Buyback record date is Jul 04, 2024.
Ajanta Pharma Limited | eClerx Services Limited | |
---|---|---|
Record Date | May 30, 2024 | Jul 04, 2024 |
Offer Open Date | Jun 05, 2024 | Jul 09, 2024 |
Offer Closure Date | Jun 11, 2024 | Jul 15, 2024 |
Last date for receipt of tender forms | Jun 11, 2024 | Jul 15, 2024 |
Finalisation of buyback | Jun 18, 2024 | |
Last Date for settlment of bids | Jun 19, 2024 | Jul 22, 2024 |
Last Date for extinguishment of shares | Jun 28, 2024 | Jul 30, 2024 |
Comparison of Ajanta Pharma Buyback 2024 and eClerx Services Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Ajanta Pharma Limited | eClerx Services Limited | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Ajanta Pharma Limited Financial Information (Restated Consolidated)Ajanta Pharma Limited's revenue increased by 11.77% and profit after tax (PAT) rose by 38.81% between the financial year ending with March 31, 2024 and March 31, 2023.
|
eClerx Services Limited Financial Information (Restated Consolidated)eClerx Services Limited's revenue increased by 10.22% and profit after tax (PAT) rose by 4.61% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|